LifePoint Health, Inc. (LPNT) Downgraded to C+ at TheStreet

LifePoint Health, Inc. (NASDAQ:LPNT) was downgraded by equities researchers at TheStreet from a “b-” rating to a “c+” rating in a research report issued on Wednesday.

A number of other analysts also recently weighed in on LPNT. Barclays PLC upped their target price on LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a research report on Monday, May 1st. Morgan Stanley started coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price for the company. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and upped their target price for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a research report on Wednesday, June 14th. Finally, Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research report on Tuesday, July 4th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company. LifePoint Health has a consensus rating of “Hold” and an average target price of $66.18.

LifePoint Health (LPNT) opened at 56.80 on Wednesday. The company has a 50-day moving average price of $62.24 and a 200 day moving average price of $62.72. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $70.95. The company has a market capitalization of $2.28 billion, a PE ratio of 12.72 and a beta of 0.86.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same period in the previous year, the company posted $0.69 EPS. On average, equities research analysts forecast that LifePoint Health will post $4.07 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “LifePoint Health, Inc. (LPNT) Downgraded to C+ at TheStreet” was posted by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.com-unik.info/2017/08/18/lifepoint-health-inc-lpnt-downgraded-to-c-at-thestreet.html.

In related news, Chairman William F. Carpenter III sold 82,347 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the sale, the chairman now owns 504,535 shares in the company, valued at approximately $32,365,920.25. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the sale, the chairman now owns 439,841 shares in the company, valued at approximately $28,616,055.46. The disclosure for this sale can be found here. 7.28% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares during the last quarter. LS Investment Advisors LLC raised its position in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares during the last quarter. US Bancorp DE raised its position in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares during the last quarter. Bank of Montreal Can raised its position in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares during the last quarter. Finally, Shelton Capital Management purchased a new position in shares of LifePoint Health during the second quarter valued at about $205,000. Institutional investors own 99.59% of the company’s stock.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit